TIV1c

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines

Conditions

Influenza

Phase 3

Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

CompletedNCT01992107

Novartis VaccinesInfluenza

Start: 2013-11-30End: 2014-08-31Updated: 2015-12-08

Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

CompletedNCT01992094

Novartis VaccinesInfluenza

Start: 2013-11-30End: 2014-07-31Updated: 2015-12-10

Related Papers

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial.

2015-11-1423 citations